🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the initial efficacy and safety of paclitaxel for injection (al...
Status
Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2024-05-19
Trial ID
NCT06415669
Treatments Being Tested
Evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of ...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-11-12
Trial ID
NCT07241767
This study is a multicenter, open-label, dose-finding/efficacy-expanding ph...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2024-06-12
Trial ID
NCT06439589
Treatments Being Tested
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Affiliated Cancer Hospital of Shandong First Medical University
Start Date
2025-07-08
Trial ID
NCT07028281
Treatments Being Tested
This is a multi-center, single-arm, phase II clinical study designed to obs...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-30
Trial ID
NCT06508229
Treatments Being Tested
This is a prospective, single-arm study to investigate the efficacy and saf...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-15
Trial ID
NCT06299371
Treatments Being Tested
This study is an open-label, multicenter Phase IB/II clinical trial to eval...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2024-07-02
Trial ID
NCT06474455
This is Phase 1 study FIH to check "Dose Escalation, Dose expansion and Ind...
Status
Completed
Location
Icon Cancer Centre
Start Date
2021-11-23
Trial ID
NCT05082545
Treatments Being Tested
In phase II, the main objective is to evaluate the efficacy of SHR-A2102 co...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-04-25
Trial ID
NCT06879145
Treatments Being Tested
This study was an open, multicenter, dose-increasing/investigational Phase ...
Status
Recruiting
Location
Shanghai Chest hospital
Start Date
2022-09-15
Trial ID
NCT05482568
Treatments Being Tested